Injection Site Reaction | ClinicalTrials HQ

View definition

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.	AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Extravasation of Diagnostic and Therapeutic Materials, Genital Diseases, HIV infectious disease, Infections, Injection Site Reaction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Not stated	2026-07-14		NCT07703748
A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV	Blood-Borne Infections, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Extravasation of Diagnostic and Therapeutic Materials, Genital Diseases, HIV infectious disease, Infections, Injection Site Reaction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 1	2025-11-28		NCT06970223